Paul Hayashi
Overview
Explore the profile of Paul Hayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao T, Xia M, Hayashi P, Pan B, Aithal G, Lucena M, et al.
Liver Int
. 2025 Jan;
45(2):e70011.
PMID: 39868816
Background And Aims: Acute liver failure (ALF) is a serious condition, typically in individuals without prior liver disease. Drug-induced ALF (DIALF) constitutes a major portion of ALF cases. Our research...
2.
Tesfaldet B, Patel T, Chen M, Pucino F, Rosario L, Hayashi P, et al.
Drug Saf
. 2024 Apr;
47(7):699-710.
PMID: 38642292
Introduction: On-treatment excursions of liver laboratory test values in clinical trials involving subjects with underlying liver disease are relevant for the efficacy and safety assessment of drug products and biologics....
3.
Liao T, Pan B, Hong H, Hayashi P, Rule J, Ganger D, et al.
Clin Transl Gastroenterol
. 2022 Jul;
13(7):e00502.
PMID: 35905417
Introduction: Indeterminate acute liver failure (IND-ALF) is a rare clinical syndrome with a high mortality rate. Lacking a known etiology makes rapid evaluation and treatment difficult, with liver transplantation often...
4.
Whritenour J, Ko M, Zong Q, Wang J, Tartaro K, Schneider P, et al.
J Immunotoxicol
. 2017 Jan;
14(1):31-38.
PMID: 28121193
Drug-induced liver injury (DILI) is a growing problem. Diagnostic methods to differentiate DILI caused by an adaptive immune response from liver injury of other causes or to identify the responsible...
5.
Fontana R, Hayashi P, Bonkovsky H, Kleiner D, Kochhar S, Gu J, et al.
Dig Dis Sci
. 2013 Feb;
58(6):1766-75.
PMID: 23377559
Aims: The aim of this study was to describe the presenting features and outcomes of consecutive patients with liver injury attributed to interferon beta. Methods: The presenting features of eight...
6.
Kozlowski T, Rubinas T, Nickeleit V, Woosley J, Schmitz J, Collins D, et al.
Liver Transpl
. 2011 Mar;
17(4):357-68.
PMID: 21445918
The importance of antibody-mediated rejection (AMR) in ABO-compatible liver transplantation is controversial. Here we report a prospective series of liver recipients with a preoperative positive crossmatch. To establish the diagnosis...
7.
Kierans A, Leonardou P, Hayashi P, Brubaker L, Elazzazi M, Shaikh F, et al.
Magn Reson Imaging
. 2010 Apr;
28(6):790-6.
PMID: 20427139
Purpose: The purpose of this study is to determine the magnetic resonance imaging (MRI) and patient characteristics in subjects with hepatocellular carcinoma (HCC) that exhibit rapid progression. Materials And Methods:...
8.
Fong T, Klontz K, Canas-Coto A, Casper S, Durazo F, Davern 2nd T, et al.
Am J Gastroenterol
. 2010 Jan;
105(7):1561-6.
PMID: 20104221
Objectives: Muscletech Hydroxycut (Iovate Health Sciences Research, Oakville, Ontario, Canada) was a popular weight-loss supplement that was recalled by the manufacturer in May 2009 on the basis of reports of...
9.
Harrison S, Torgerson S, Hayashi P, Ward J, Schenker S
Am J Gastroenterol
. 2003 Nov;
98(11):2485-90.
PMID: 14638353
Objective: Nonalcoholic steatohepatitis (NASH) is a common cause of liver disease. Although usually indolent, this disease can progress to cirrhosis in some patients. There is currently no proven medical therapy...
10.
Hayashi P, Trotter J, Everson G
Liver Transpl
. 2003 Oct;
9(11):1225-6.
PMID: 14586886
No abstract available.